1,973.00
-2.8(-0.14%)
Currency In INR
Address
Plot No. 11 & 84, TSIIC Phase: IV
Hyderabad, 502307
India
Phone
91 84 5569 9999
Website
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
4217
First IPO Date
November 20, 2020
Name | Title | Pay | Year Born |
Mr. Shyamakant Giri | Chief Executive Officer | 0 | N/A |
Mr. Sampath Kumar Pallerlamudi | Company Secretary & Vice-President of Compliance & CSR | 6.05M | 1981 |
Mr. Ravi Shekhar Mitra | Chief Financial Officer | 20.45M | 1977 |
Mr. Srinivas Sadu | Executive Chairman | 70.15M | 1969 |
Mr. Surinder Koul | Head of Domestic Marketing | 0 | N/A |
Mr. R.V.R. Prabhakara Sastry | Senior Vice President of R&D | 0 | N/A |
Mr. Rong Wu | Chief Financial Controller | 0 | N/A |
Mr. Satnam Singh Loomba | Chief Operating Officer | 0 | 1968 |
Mr. K Raghuramachandra Rao | Head of Quality | 0 | N/A |
Gland Pharma Limited engages in the development, manufacture, and marketing of injectable-focused generic liquid parenteral products. The company's primary molecules include heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, as well as others. It offers its products under various therapeutic categories, such as anti-infectives, anesthetics, anti-coagulants and their antidotes, anti-malarial, cardiology, gastro-intestinal, pain management, hormones and related drugs, fertility supplements, Gnrh agonists and antagonists, anti-neoplastic, gynecological, neurological and central nervous system, respiratory, blood related, ophthalmological and otological, pain/analgesics, orthopedics, hematinic, vitamins/minerals/nutrients, and others. The company also provides contract development services. It sells its products primarily under a business to business in the United States, Europe, Canada, Australia, India, and internationally. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited is a subsidiary of Fosun Pharma Industrial Pte. Ltd.